Gujarat Themis Biosyn Ltd
GUJTHEMGujarat Themis Biosyn Ltd
GUJTHEMPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
53.49 | 19.71 | 0.27% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.87 | 5.94 | 0.55% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The company makes bulk drugs. It's R&D division focuses on developing fermentation cultures. The Company's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 31.55 | 32.79 | 36.05 | 38.97 | 43.26 | 86.82 | 93.83 | 118.90 | 154.99 | 160.74 | ||||||||||
Raw Materials | 0.29 | 0.32 | 1.49 | 2.15 | 1.30 | 15.44 | 15.75 | 21.75 | 29.73 | 83.27 | ||||||||||
Power & Fuel Cost | 16.16 | 17.15 | 17.99 | 19.33 | 20.20 | 22.86 | 16.57 | 21.73 | 26.41 | |||||||||||
Employee Cost | 4.00 | 4.28 | 4.42 | 4.46 | 5.17 | 6.43 | 7.11 | 7.08 | 7.75 | |||||||||||
Selling & Administrative Expenses | 0.95 | 0.94 | 0.85 | 1.10 | 1.39 | 1.64 | 1.86 | 2.31 | 6.66 | |||||||||||
Operating & Other expenses | 3.79 | 3.90 | 4.90 | 5.52 | 5.62 | 6.91 | 8.94 | 3.94 | 4.20 | |||||||||||
EBITDA | 6.36 | 6.20 | 6.40 | 6.41 | 9.58 | 33.54 | 43.60 | 62.09 | 80.24 | 77.47 | ||||||||||
Depreciation/Amortization | 1.38 | 1.20 | 1.12 | 1.15 | 1.22 | 1.36 | 1.73 | 2.23 | 2.58 | 3.38 | ||||||||||
PBIT | 4.98 | 5.00 | 5.28 | 5.26 | 8.36 | 32.18 | 41.87 | 59.86 | 77.66 | 74.09 | ||||||||||
Interest & Other Items | 0.39 | 0.38 | 0.41 | 0.42 | 0.16 | 0.92 | 0.98 | 0.83 | 0.20 | 0.18 | ||||||||||
PBT | 4.59 | 4.62 | 4.87 | 4.84 | 8.20 | 31.26 | 40.89 | 59.03 | 77.46 | 73.91 | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.50 | 0.97 | 1.79 | 7.59 | 10.71 | 15.41 | 19.50 | 18.95 | ||||||||||
Net Income | 4.59 | 4.62 | 4.37 | 3.87 | 6.41 | 23.67 | 30.18 | 43.62 | 57.96 | 54.96 | ||||||||||
EPS | 0.63 | 0.64 | 0.60 | 0.53 | 0.88 | 3.26 | 4.15 | 6.00 | 7.98 | 7.57 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 0.00 | 2.20 | 1.08 | 0.20 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.37 | 0.14 | 0.03 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Gujarat Themis Biosyn Ltd | 50.72 | 19.71 | 0.27% |
Sun Pharmaceutical Industries Ltd | 43.04 | 6.15 | 0.76% |
Cipla Ltd | 40.52 | 4.79 | 0.60% |
Dr Reddy's Laboratories Ltd | 22.98 | 4.45 | 0.64% |
Price Comparison
Compare GUJTHEM with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 4.13%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Gujarat Themis Biosyn Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
quant Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4376% | Percentage of the fund’s portfolio invested in the stock 4.87% | Change in the portfolio weight of the stock over the last 3 months 4.87% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 11/27 (+8) |
quant Manufacturing Fund - Growth Option - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3301% | Percentage of the fund’s portfolio invested in the stock 1.77% | Change in the portfolio weight of the stock over the last 3 months 1.77% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/41 (+2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 22, 2024
Dividend/Share
₹0.75
Ex DateEx Date
Feb 22, 2024
Cash Dividend
Ex DateEx DateSep 1, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 1, 2023
Cash Dividend
Ex DateEx DateDec 1, 2022
Dividend/Share
₹4.40
Ex DateEx Date
Dec 1, 2022
Cash Dividend
Ex DateEx DateAug 29, 2022
Dividend/Share
₹4.00
Ex DateEx Date
Aug 29, 2022
Cash Dividend
Ex DateEx DateNov 24, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Nov 24, 2021
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 31.8%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0.02% to 0.05%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 71.82%, vs industry avg of 9.82%